RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,599,416 | +171.7% | 470,512 | +165.3% | 0.00% | +200.0% |
| Q2 2023 | $1,324,715 | -71.1% | 177,338 | -74.2% | 0.00% | -66.7% |
| Q1 2023 | $4,590,461 | +155.7% | 688,225 | +195.6% | 0.00% | +200.0% |
| Q4 2022 | $1,795,096 | +4.4% | 232,827 | +44.1% | 0.00% | 0.0% |
| Q3 2022 | $1,719,000 | +1619.0% | 161,560 | +1213.5% | 0.00% | – |
| Q2 2022 | $100,000 | -5.7% | 12,300 | -17.4% | 0.00% | – |
| Q1 2022 | $106,000 | -97.5% | 14,899 | -93.9% | 0.00% | -100.0% |
| Q4 2021 | $4,186,000 | +301.7% | 244,357 | +439.5% | 0.00% | +100.0% |
| Q3 2021 | $1,042,000 | +2716.2% | 45,294 | +4402.4% | 0.00% | – |
| Q2 2021 | $37,000 | – | 1,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |